Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from LLY

Dow Jones Futures Rise: Bullish Market Breadth, But Fed Looms; Nvidia Has New Buy Point

A broader market rally is a reason to be bullish long term, but the Fed meeting is one reason to be cautious now. Biogen jumped late Friday. Watch Tesla and Nvidia.

Investors Business Daily

Eli Lilly Stock Doesn't Have To Shoot Higher For Profits

If Eli Lilly stays around 440, this calendar spread profits on its neutral outlook.

Investors Business Daily

Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review

The stock market rally went to "under pressure" amid big earnings moves and revived banking fears, but the major indexes ultimately closed tightly again.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Lilly Has Plans For Possible Anti-Obesity Medication. Here's How To Make Money With LLY Options

This trade is a neutral to bullish position and anticipates the stock holding above 390 over the summer term.

Investors Business Daily

Dow Jones Futures Rise: Meta Soars, Drug Giants Climb, Specialty Chip Plays Dive

Futures: Meta Platforms boomed on earnings, but megacap techs can't hide broad market rally weakness. First Republic dived again.

Investors Business Daily

3 Safe Stocks to Buy Hand Over Fist Right Now

The recent financial system failures and macroeconomic headwinds have weighed heavily on investors’ sentiments. Amid rekindled recessionary fears, quality stocks Eli Lilly (LLY), McDonald's Corp. (MCD), and Cigna Corp. (CI) might be safe portfolio additions now. Read on….

StockNews.com

5 Best Pharma Stocks to Buy Right Now

The pharma industry has experienced tremendous growth in recent years and should continue to grow amid the integration of advanced technologies. Hence, pharma stocks Eli Lilly (LLY), Takeda Pharmaceutical (TAK), Catalyst Pharmaceuticals (CPRX), Poseida Therapeutics (PSTX), and Voyager Therapeutics (VYGR) might be worth buying right now. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

The 5 Safest Stocks You Can Buy in 2023

The stock market might remain volatile in the near term amid the still-alarmingly high inflation and the anticipated continuation of rate hikes. Therefore, fundamentally strong Eli Lilly (LLY), Novartis (NVS), Comcast (CMCSA), HCA Healthcare (HCA), and Myers Industries (MYE), which pay steady dividends, might be safe buys now. Read more.

StockNews.com

3 Large-Cap Stocks to Buy for the Perfect Portfolio in 2023

While the easing inflation and strong labor market have been boosting consumer confidence, uncertainties remain. Moreover, the Fed’s interest rate hikes might continue longer than many think. Therefore, fundamentally sound large-cap stocks, Visa (V), Eli Lilly (LLY), and Merck & Co (MRK), could be ideal buys to navigate the economic…

StockNews.com

3 Smart Stocks to Buy for a Potential Recession

Despite the cooling inflation, the Fed is not expected to cut rates in 2023 as it is committed to achieving its 2% inflation target. Continued rate hikes, albeit at a lower rate, could potentially push the economy into a recession this year. Amid lingering recession fears, it could be wise…

StockNews.com

Eli Lilly Dives After A 'Bump In The Road' Shakes Its Newest Diabetes Drug

Eli Lilly experienced a "bump in the road" for its newest diabetes treatment, Mounjaro, an analyst said Thursday as LLY stock toppled.

Investors Business Daily

Tech Futures Jump As Meta Spikes After 'Gratifying' Fed Rally; Apple, Amazon, Google Earnings Next

Tech futures leapt as Meta spiked on its results, following the Fed's "gratifying" market rally. Apple, Amazon, Google earnings are next.

Investors Business Daily

4 Pharma Stocks You Shouldn’t Think Twice About Buying in 2023

Pharma sector usually performs relatively well amid market turmoil due to the inelastic demand for its offerings. Moreover, increased technological advancements should boost the industry’s growth. Hence, pharma stocks Eli Lilly (LLY), AstraZeneca (AZN), Zoetis (ZTS), and Teva Pharmaceutical (TEVA) might be worth buying in 2023. Read more.

StockNews.com

The 3 Best Retirement Stocks to Buy for Investors Over 55

While moderation of the inflation rate is December has triggered a bear market rally, the stock market is unlikely to stabilize in the near term because of the likelihood of further interest rate hikes. Hence, shares of fundamentally strong and growing businesses with a track record of increasing dividend payouts,…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Large-Cap Stocks Worth Buying in 2023

With the Fed signaling to continue raising interest rates throughout this year, the probability of the economy tipping into a recession is increasing. Amid the macroeconomic unrest, fundamentally sound large-cap stocks UnitedHealth Group (UNH), Walmart (WMT), and Eli Lilly (LLY) might be safe investments this year. Read on….

Investors Business Daily

Dow Jones Futures Rise With Key Data Due After Market Hit Resistance To Start 2023

Dow Jones futures: The market started 2023 where it left off: flashes of strength with reversals at resistance. Apple and Tesla stock dived.

Investors Business Daily

IBD Stock Of The Day: How These Issues In 2023 Could Spark, Or Slam, Eli Lilly Stock

Eli Lilly is the IBD Stock Of The Day as the company explores new methods of treating Alzheimer's and obesity, driving LLY stock near highs.

Investors Business Daily

The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly Stock

Investors are closely watching two Eli Lilly battles that will unfold in 2023 as LLY stock continues a fevered streak, tacking on new highs.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Large-Cap Stocks to Add to Your Portfolio Now

The Fed’s aggressive stance on inflation has weighed heavily on the stock market this year. As large-cap stocks usually can weather challenging economic conditions, sound large-cap stocks Eli Lilly (LLY), Agilent Technologies (A), and Fortinet (FTNT) might be wise additions to your portfolio. Keep reading.

Investors Business Daily

The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen

Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testing, but LLY stock dipped on guidance.

Investors Business Daily

How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

Investors Business Daily

Medical Stocks Lead List Of New Buys By The Best Mutual Funds

The best mutual funds scooped up shares of MRK, LLY, ABBV and AMGN, while also adding retailers like WING to their holiday lists

StockNews.com

2 Giant Stocks to Consider Buying Right Now and 1 to Avoid

With slower but surer interest rate hikes expected to put further pressure on the compressed margins of most companies and enhance the odds of an economic slowdown, the market is unlikely to stabilize anytime soon. Hence, it could be wise to load up on steady stocks, Microsoft (MSFT) and Eli…

StockNews.com

3 Pharmaceutical Stocks to Invest in This Month

The pharmaceutical industry is rapidly evolving to meet today’s health challenges. The pharmaceutical industry's long-term prospects look bright with a globally aging population set to increase healthcare expenditure. Moreover, given the industry’s ability to stay resilient amid economic headwinds, it could be wise to invest in fundamentally strong pharmaceutical stocks…

Investors Business Daily

Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads

Eli Lilly reportedly is pulling advertising from Twitter after a fake account promised free insulin in a fiasco that depressed LLY stock.

1 … 4 5 6 7

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations